Earnings History Data for NovaBay Pharmaceuticals (NBY) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | NBY | NovaBay Pharmaceuticals | 4.00 | -0.60 | -0.28 | 0.00 | NovaBay GAAP EPS of -$0.60 misses by $0.30, revenue of $2.44M misses by $0.19M [11/8/2024 12:01 AM] |
0.7019 | 0.0 (0.41%) |
0.70 | 0.0 (0.14%) |
0.36 - 12.58 | 201,724 | 2,160,000 | 6,557 | ||
| 13-08-2024 | AH | NBY | NovaBay Pharmaceuticals, Inc. | 0.44 | -1.37 | 0.00 | -44.41 | NovaBay GAAP EPS of -$1.37 misses by $0.14, revenue of $2.4M misses by $0.75M [8/13/2024 4:21 PM] |
0.4843 | 0.0 (0.92%) |
0.47 | -0.01 (-1.75%) |
0.36 - 44.80 | 712,967 | 410,000 | 10,464 | ||
| 09-05-2024 | AH | NBY | NovaBay Pharmaceuticals, Inc. | 2.60 | -0.14 | 0.00 | -0.85 | NovaBay GAAP EPS of -$0.15 in-line, revenue of $2.63M misses by $0.65M [5/9/2024 4:11 PM] |
0.0804 | -0.01 (-9.91%) |
0.08 | 0.0 (-4.93%) |
0.06 - 1.28 | 1,716,951 | 2,660,000 | 61,056 | ||
| 09-11-2023 | AH | NBY | NovaBay Pharmaceuticals, Inc. | 1.45 | -0.37 | 0.00 | -3.50 | NovaBay GAAP EPS of -$0.37 beats by $0.04, revenue of $3.27M misses by $0.27M [11/9/2023 4:16 PM] |
0.3202 | -0.03 (-8.23%) |
0.33 | -0.02 (-5.39%) |
0.31 - 3.63 | 54,222 | 60,000 | 2,648 | ||
| 11-05-2023 | AH | 4:05 PM ET (May 11) |
NBY | NovaBay Pharmaceuticals, Inc. | 1.99 | -0.85 | 0.00 | 0.00 | NovaBay GAAP EPS of -$0.85 beats by $0.06, revenue of $3.12M misses by $0.08M [5/11/2023 4:17 PM] |
0.9550 | -0.04 (-4.47%) |
0.95 | -0.05 (-5.18%) |
0.85 - 12.64 | 1,348,074 | 90,000 | 17,310 | |
| 30-03-2023 | AH | 4:05 PM ET (Mar 30) |
NBY | NovaBay Pharmaceuticals, Inc. | 4.13 | -4.33 | 0.00 | -0.70 | 1.65 | -0.07 (-4.04%) |
0.0 | 0.0 (0.00%) |
1.24 - 12.64 | 12,281 | 10,000 | 0 | ||
|
|
||||||||||||||||||
| 14-11-2022 | AH | 4:05 PM ET (Nov 14) |
NBY | NovaBay Pharmaceuticals, Inc. | 5.20 | -0.10 | 0.00 | -0.05 | NovaBay GAAP EPS of -$0.10, revenue of $3.83M [11/14/2022 4:13 PM] |
0.0853 | -3.06 (-97.29%) |
0.10 | -3.04 (-96.82%) |
0.08 - 20.65 | 9,330,649 | 20,000 | 686,947 | |
|
||||||||||||||||||
| 11-08-2022 | AH | 4:05 PM ET (Aug 11) |
NBY | NovaBay Pharmaceuticals, Inc. | 12.63 | -0.04 | 0.00 | -0.04 | NovaBay GAAP EPS of -$0.04 in-line, revenue of $3.04M misses by $0.47M [8/11/2022 4:14 PM] |
0.2798 | -0.03 (-8.29%) |
0.30 | -0.01 (-1.67%) |
0.17 - 0.77 | 803,466 | 1,470,000 | 11,043 | |
| 12-05-2022 | AH | 4:05 PM ET (May 12) |
NBY | NovaBay Pharmaceuticals, Inc. | 10.29 | N/A | 0.00 | -0.04 | NovaBay GAAP EPS of $0.00 beats by $0.03, revenue of $2.63M misses by $0.63M [5/12/2022 4:17 PM] |
0.1943 | 0.01 (6.44%) |
0.20 | 0.02 (12.33%) |
0.17 - 0.88 | 854,010 | 380,000 | 996 | |
| 29-03-2022 | AH | 4:05 PM ET (Mar 29) |
NBY | NovaBay Pharmaceuticals, Inc. | 16.19 | -0.02 | 0.00 | -0.04 | NovaBay GAAP EPS of -$0.02 beats by $0.03, revenue of $2.64M misses by $0.71M [3/29/2022 4:25 PM] |
0.3074 | -0.01 (-3.94%) |
0.31 | -0.01 (-3.09%) |
0.26 - 1.02 | 449,030 | 500,000 | 25,186 | |
| 12-08-2021 | AH | 4:05 PM ET (Aug 12) |
NBY | NovaBay Pharmaceuticals, Inc. | 26.70 | -0.04 | 0.00 | -0.15 | NovaBay EPS in-line, beats on revenue [8/12/2021 4:24 PM] |
0.6397 | -0.01 (-1.75%) |
0.64 | -0.01 (-1.32%) |
0.52 - 1.79 | 1,585,432 | 3,320,000 | 3,460 | |
| 06-05-2021 | AH | 4:05 PM ET (May 6) |
NBY | NovaBay Pharmaceuticals, Inc. | 33.13 | -0.04 | 0.00 | -0.06 | NovaBay EPS in-line, misses on revenue [5/6/2021 4:45 PM] |
0.7274 | -0.02 (-2.03%) |
0.72 | -0.02 (-2.96%) |
0.52 - 1.94 | 634,763 | 460,000 | 5,145 | |
| 25-03-2021 | AH | 4:05 PM ET (Mar 25) |
NBY | NovaBay Pharmaceuticals, Inc. | 43.45 | -0.04 | 0.00 | -0.13 | NovaBay EPS in-line, misses on revenue [3/25/2021 4:14 PM] |
0.9198 | -0.06 (-6.15%) |
0.94 | -0.04 (-4.06%) |
0.52 - 1.94 | 1,187,350 | 3,230,000 | 54,659 | |
| 12-11-2020 | AH | 4:05 PM ET (Nov 12) |
NBY | NovaBay Pharmaceuticals, Inc. | 24.21 | -0.08 | 0.00 | -0.02 | NovaBay EPS misses by $0.04, misses on revenue [11/12/2020 4:10 PM] |
0.6106 | -0.04 (-6.05%) |
0.5489 | -0.10 (-15.54%) |
0.24 - 1.94 | 1,512,577 | 908,308 | 130,679 | |
|
|
||||||||||||||||||
| 06-08-2020 | AH | 4:05 PM ET (Aug 6) |
NBY | NovaBay Pharmaceuticals, Inc. | 44.06 | -0.15 | 0.00 | -0.14 | NovaBay EPS misses by $0.09, beats on revenue [8/6/2020 4:25 PM] |
1.15 | -0.18 (-13.68%) |
1.12 | -0.21 (-15.79%) |
0.24 - 1.94 | 2,458,650 | 2,915,289 | 448,938 | |
|
|
||||||||||||||||||